Headquarters
55 CAMBRIDGE PKWY STE 102W, CAMBRIDGE, MA 02142-1234, US
CAMBRIDGE, MA, US
COGNITO THERAPEUTICS GROUP, INC.
From the company
Cognito Therapeutics is developing novel therapeutics for neurodegenerative diseases, including a non-invasive neuroprotective therapy called Spectris for Alzheimer's disease. Spectris delivers audiovisual stimulation designed to evoke gamma wave activity, and received FDA Breakthrough Device Designation for treatment of cognitive and functional symptoms associated with Alzheimer's disease. The company was founded by MIT neuroscientists Ed Boyden and Li-Huei Tsai.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.